paroxetine has been researched along with Learning Disabilities in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amleh, I; Bannoura, I; Danoun, OA; Gluck, MA; Herzallah, MM; Moustafa, AA; Myers, CE; Natsheh, JY; Petrides, G; Sehwail, MA; Simon, JR; Tayem, YI | 1 |
Baas, JM; Bijlsma, EY; Groenink, L; Hendriksen, H; Millan, MJ | 1 |
2 other study(ies) available for paroxetine and Learning Disabilities
Article | Year |
---|---|
Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder.
Topics: Adolescent; Adult; Cognition; Depressive Disorder, Major; Female; Generalization, Psychological; Humans; Learning Disabilities; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2013 |
Lifelong disturbance of serotonin transporter functioning results in fear learning deficits: Reversal by blockade of CRF1 receptors.
Topics: Animals; Basolateral Nuclear Complex; Disease Models, Animal; Dorsal Raphe Nucleus; Fear; Gene Knockout Techniques; Learning; Learning Disabilities; Male; Neurotransmitter Agents; Paroxetine; Prepulse Inhibition; Pyrimidines; Pyrroles; Rats, Transgenic; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Reflex, Startle; RNA-Binding Proteins; RNA, Messenger | 2015 |